1.
Pharmacogenetics and adverse drug reactions
by Meyer, Urs A
The Lancet (British edition), 2000, Vol.356 (9242), p.1667-1671
2.
Human cytochrome P450 epoxygenases: Variability in expression and role in inflammation-related disorders
by Shahabi, Payman
Alimentary Pharmacology & Therapeutics (Suppl), 2014, Vol.144 (2), p.134-161
3.
Omics and Drug Response
by MEYER, Urs A
Annual review of pharmacology and toxicology, 2013, Vol.53 (1), p.475-502
4.
Introduction to the Theme "Cancer Pharmacology"
by Insel, Paul A
Annual review of pharmacology and toxicology, 2016, Vol.56 (1), p.19-22
5.
Molecular mechanisms of genetic polymorphisms of drug metabolism
by Meyer, U A
Annual review of pharmacology and toxicology, 1997, Vol.37 (1), p.269-296
6.
The evolution of drug-activated nuclear receptors: one ancestral gene diverged into two xenosensor genes in mammals
by Handschin, Christoph
Nuclear receptor, 2004, Vol.2 (1), p.7-7
7.
Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
by Heim, M
The Lancet (British edition), 1990, Vol.336 (8714), p.529-532
8.
Isoniazid plus Sulphadoxine-Pyrimethamine Can Reduce Morbidity of HIV-Positive Patients Treated for Tuberculosis in Africa: A Controlled Clinical Trial
by Haller, Louis
Chemotherapy (Basel), 1999, Vol.45 (6), p.452-465
9.
Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
by Gonzalez, Frank J
Nature (London), 1988, Vol.331 (6155), p.442-446
10.
Introduction to the "Theme Pharmacology"
by Insel, Paul A
Annual review of pharmacology and toxicology, 2016, Vol.56, p.19-22
11.
Cytochrome P450 enzymes
by Meyer, Urs A.
Drug metabolism and drug interactions, 2012, Vol.27 (1), p.1-2
12.
Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism
by GAEDIGK, A
American journal of human genetics, 1991, Vol.48 (5), p.943-950
13.
The human CYP2D locus associated with a common genetic defect in drug oxidation : A G1934→a base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recog...
by HANIOKA, N
American journal of human genetics, 1990, Vol.47 (6), p.994-1001
14.
15.
The evolution of drug-activated nuclear receptors: one ancestral gene
by Handschin, Christoph
Nuclear receptor, 2004, Vol.2
19.
Stoffwechsel des Fettgewebes normaler, alloxandiabetischer und nach Nahrungskarenz wiedergef tterter Ratten w hrend langfristiger Inkubation in vitro
by Meyer, Urs A.
Diabetologia, 1966, Vol.2 (3), p.189-194
20.
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?
by Meyer, Urs
Pediatric research, 2011, Vol.69 (5 Pt 2), p.26R-33R
